PCOS Gets New Name After Worldwide Patient Survey

After decades of confusion, a hormonal disorder affecting millions of women finally has a name that makes sense.

Polycystic ovary syndrome, or PCOS, is now called polyendocrine metabolic ovarian syndrome, or PMOS. The change comes after a years-long effort involving thousands of patients and healthcare workers across 56 organizations worldwide.

"It was very clear that the name was inaccurate," said Dr. Helena Teede, who led the international steering group behind the change. She's an endocrinologist and professor of women's health at Monash University in Australia.

The old name created real problems. It suggested women with the condition had abnormal cysts on their ovaries, but that's not what's happening at all.

When doctors first described the syndrome in the 1930s, they noticed ovaries looked bumpy during surgery. They thought these were cysts, but research has since shown they're actually arrested follicles, meaning eggs that failed to mature due to hormonal disruptions.

True ovarian cysts can rupture, bleed, and require surgery. Women with PMOS aren't any more likely to have these dangerous cysts than anyone else.

The misleading name had consequences. Up to 70% of people with PMOS remain undiagnosed, partly because doctors and patients misunderstand what the condition involves.

The old name also ignored the bigger picture. PMOS disrupts multiple hormones and affects metabolism, weight, mental health, skin, and reproduction. By focusing only on ovaries, the name made it seem like just a gynecological issue.

The Ripple Effect

The new name could transform how medicine approaches this common condition. Because PCOS was viewed as reproductive, research funding and medical education focused heavily on fertility while neglecting other body systems.

In recent surveys, 86% of patients and 76% of health professionals agreed the name needed to change. The process wasn't quick or easy, though.

Calls for a new name date back to the 1990s. In 2012, the National Institutes of Health officially recommended changing it, calling the old name a confusing "distraction."

This time, organizers made sure to do it right. They surveyed thousands of people worldwide and included patient advocacy groups at every stage, ensuring the decision reflected what patients actually wanted.

Choosing "polyendocrine" and "metabolic" got strong support because these terms capture how the condition affects multiple hormone systems and metabolism. "Ovarian" stayed in the name rather than "reproductive" because, in many cultures, linking a condition to fertility can harm women.

"In many cultures, the worth or value of a woman is linked to her fertility," Teede explained. "So, implying that women have a condition that might impact that can be very harmful."

A three-year awareness campaign will help doctors and patients adopt the new name. When diagnosed and treated appropriately, people with PMOS can manage their symptoms effectively and live healthy lives.